Tentarix Biotherapeutics Funding: $132M Raised, Series B
Tentarix Biotherapeutics is based in San Diego. It has raised $132M in total funding. Latest round: Series B.
Tentarix Biotherapeutics funding overview
Tentarix Biotherapeutics is based in San Diego. Tentarix Biotherapeutics has raised $132M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2023. The round record for Tentarix Biotherapeutics runs through 2023; nothing later has been disclosed. Investors on record include Amplitude Ventures, Gilead Sciences, Inc., Versant Ventures, Samsara BioCapital. 4 distinct backers are named across the disclosed rounds.
Frequently asked about Tentarix Biotherapeutics funding
How much has Tentarix Biotherapeutics raised?
Tentarix Biotherapeutics has raised $132M in total disclosed funding across the rounds on record.
Who has invested in Tentarix Biotherapeutics?
Amplitude Ventures, Gilead Sciences, Inc., Versant Ventures, Samsara BioCapital are named among the investors backing Tentarix Biotherapeutics.
What was the latest Tentarix Biotherapeutics funding round?
The most recent disclosed round is a Series B, announced in September 2023.
Where is Tentarix Biotherapeutics based?
Tentarix Biotherapeutics is based in San Diego.
When did Tentarix Biotherapeutics last raise?
The last disclosed Tentarix Biotherapeutics round closed in September 2023 at Series B.
Totals shown for Tentarix Biotherapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.
Companies related to Tentarix Biotherapeutics (26)
